The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow
Open accessAbstract
Breast cancer cells frequently home to the bone marrow, where they may enter a dormant state before forming a bone metastasis. Several members of the interleukin-6 (IL-6) cytokine family are implicated in breast cancer bone colonization, but the role for the IL-6 cytokine leukaemia inhibitory factor (LIF) in this process is unknown. We tested the hypothesis that LIF provides a pro-dormancy signal to breast cancer cells in the bone. In breast cancer patients, LIF receptor (LIFR) levels are lower with bone metastases and are significantly and inversely correlated with patient outcome and hypoxia gene activity. Hypoxia also reduces the LIFR:STAT3:SOCS3 signalling pathway in breast cancer cells. Loss of the LIFR or STAT3 enables otherwise dormant breast cancer cells to downregulate dormancy-, quiescence- and cancer stem cell-associated genes, and to proliferate in and specifically colonize the bone, suggesting that LIFR:STAT3 signalling confers a dormancy phenotype in breast cancer cells disseminated to bone.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
Gao, J., Aksoy, B. A., Dogrusoz, U., Dresdner, G., Gross, B., Sumer, S. O., Sun, Y., Jacobsen, A., Sinha, R., Larsson, E., et al. (2013) · Science Signaling · doi:10.1126/scisignal.2004088 · Cited by 15,160
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
Gene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
TGF-β Signaling in Tumor Suppression and Cancer Progression
Derynck, R., Akhurst, R. J., & Balmain, A. (2001) · Nature Genetics · doi:10.1038/ng1001-117 · Cited by 2,275
Metastatic Behavior of Breast Cancer Subtypes
Kennecke, H., Yerushalmi, R., Woods, R., Cheang, M. C. U., Voduc, D., Speers, C. H., Nielsen, T. O., & Gelmon, K. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.9820 · Cited by 2,262
A family of cytokine-inducible inhibitors of signalling
Starr, R., Willson, T. A., Viney, E. M., Murray, L. J. L., Rayner, J. R., Jenkins, B. J., Gonda, T. J., Alexander, W. S., Metcalf, D., Nicola, N. A., et al. (1997) · Nature · doi:10.1038/43206 · Cited by 2,066
The perivascular niche regulates breast tumour dormancy
Ghajar, C. M., Peinado, H., Mori, H., Matei, I. R., Evason, K. J., Brazier, H., Almeida, D., Koller, A., Hajjar, K. A., Stainier, D. Y. R., et al. (2013) · Nature Cell Biology · doi:10.1038/ncb2767 · Cited by 1,148 · cited 2×
“mechanisms enabling tumor cells to emerge from dormancy are poorly understood, but there is increasing evidence that tumor-stromal interactions, and the osteoblast 2, 3 , perivascular 4 and perisinusoidal 5 niche are critical mediators of tumor cell dormancy and bone colonization.”
Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
Chaffer, C. L., Brueckmann, I., Scheel, C., Kaestli, A. J., Wiggins, P. A., Rodrigues, L. O., Brooks, M., Reinhardt, F., Su, Y., Polyak, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102454108 · Cited by 1,147
Mechanisms of disseminated cancer cell dormancy: an awakening field
Sosa, M. S., Bragado, P., & Aguirre-Ghiso, J. A. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3793 · Cited by 1,126
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer
Shachaf, C. M., Kopelman, A. M., Arvanitis, C., Karlsson, Å., Beer, S., Mandl, S., Bachmann, M. H., Borowsky, A. D., Ruebner, B., Cardiff, R. D., et al. (2004) · Nature · doi:10.1038/nature03043 · Cited by 874
Guise, T. A., Yin, J. J., Taylor, S. D., Kumagai, Y., Dallas, M., Boyce, B. F., Yoneda, T., & Mundy, G. R. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118947 · Cited by 851
Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1
Thomas, R. J., Guise, T. A., Yin, J. J., Elliott, J., Horwood, N. J., Martin, T. J., & Gillespie, M. T. (1999) · Endocrinology · doi:10.1210/endo.140.10.7037 · Cited by 536
Fructose-1,6-bisphosphatase opposes renal carcinoma progression
Li, B., Qiu, B., Lee, D. S. M., Walton, Z. E., Ochocki, J. D., Mathew, L. K., Mancuso, A., Gade, T. P. F., Keith, B., Nissim, I., et al. (2014) · Nature · doi:10.1038/nature13557 · Cited by 535
Bragado, P., Estrada, Y., Parikh, F., Krause, S., Capobianco, C., Farina, H. G., Schewe, D. M., & Aguirre-Ghiso, J. A. (2013) · Nature Cell Biology · doi:10.1038/ncb2861 · Cited by 503
Bos, R., van der Groep, P., Greijer, A. E., Shvarts, A., Meijer, S., Pinedo, H. M., Semenza, G. L., van Diest, P. J., & van der Wall, E. (2003) · Cancer · doi:10.1002/cncr.11246 · Cited by 500
Bone metastasis: the importance of the neighbourhood
Croucher, P. I., McDonald, M. M., & Martin, T. J. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.44 · Cited by 479
The murine transforming growth factor-beta precursor.
Derynck, R., Jarrett, J. A., Chen, E. Y., & Goeddel, D. V. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38511-3 · Cited by 472
The BMP Inhibitor Coco Reactivates Breast Cancer Cells at Lung Metastatic Sites
Gao, H., Chakraborty, G., Lee-Lim, A. P., Mo, Q., Decker, M., Vonica, A., Shen, R., Brogi, E., Brivanlou, A. H., & Giancotti, F. G. (2012) · Cell · doi:10.1016/j.cell.2012.06.035 · Cited by 430
Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone
Kobayashi, A., Okuda, H., Xing, F., Pandey, P. R., Watabe, M., Hirota, S., Pai, S. K., Liu, W., Fukuda, K., Chambers, C., et al. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20110840 · Cited by 427
Inhibition of Metastatic Outgrowth from Single Dormant Tumor Cells by Targeting the Cytoskeleton
Barkan, D., Kleinman, H., Simmons, J. L., Asmussen, H., Kamaraju, A. K., Hoenorhoff, M. J., Liu, Z.-Y., Costes, S. V., Cho, E. H., Lockett, S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6849 · Cited by 425
Chen, D., Sun, Y., Wei, Y., Zhang, P., Rezaeian, A. H., Teruya-Feldstein, J., Gupta, S., Liang, H., Lin, H.-K., Hung, M.-C., et al. (2012) · Nature Medicine · doi:10.1038/nm.2940 · Cited by 413
Metastatic Growth from Dormant Cells Induced by a Col-I–Enriched Fibrotic Environment
Barkan, D., El Touny, L. H., Michalowski, A. M., Smith, J. A., Chu, I., Davis, A. S., Webster, J. D., Hoover, S., Simpson, R. M., Gauldie, J., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2356 · Cited by 394
The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells
Wang, H., Yu, C., Gao, X., Welte, T., Muscarella, A. M., Tian, L., Zhao, H., Zhao, Z., Du, S., Tao, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2014.11.017 · Cited by 390
(2002) · PubMed · Cited by 385
NR2F1 controls tumour cell dormancy via SOX9- and RARβ-driven quiescence programmes
Sosa, M. S., Parikh, F., Maia, A. G., Estrada, Y., Bosch, A., Bragado, P., Ekpin, E., George, A., Zheng, Y., Lam, H.-M., et al. (2015) · Nature Communications · doi:10.1038/ncomms7170 · Cited by 355
Kelly, R. D. W., & Cowley, S. M. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130010 · Cited by 297
Dales, J.-P., Garcia, S., Meunier-Carpentier, S., Andrac-Meyer, L., Haddad, O., Lavaut, M.-N., Allasia, C., Bonnier, P., & Charpin, C. (2005) · International Journal of Cancer · doi:10.1002/ijc.20984 · Cited by 261
Generali, D., Berruti, A., Brizzi, M. P., Campo, L., Bonardi, S., Wigfield, S., Bersiga, A., Allevi, G., Milani, M., Aguggini, S., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2690 · Cited by 250
Transcriptional switch of dormant tumors to fast-growing angiogenic phenotype
Almog, N., Ma, L., Raychowdhury, R., Schwager, C., Erber, R., Short, S., Hlatky, L., Vajkoczy, P., Huber, P. E., Folkman, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2590 · Cited by 240
Price, T. T., Burness, M. L., Sivan, A., Warner, M. J., Cheng, R., Lee, C. H., Olivere, L., Comatas, K., Magnani, J., Kim Lyerly, H., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad4059 · Cited by 239
Narravula, S., & Colgan, S. P. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.12.7543 · Cited by 218
Oki, T., Nishimura, K., Kitaura, J., Togami, K., Maehara, A., Izawa, K., Sakaue-Sawano, A., Niida, A., Miyano, S., Aburatani, H., et al. (2014) · Scientific Reports · doi:10.1038/srep04012 · Cited by 216
Dormancy Signatures and Metastasis in Estrogen Receptor Positive and Negative Breast Cancer
Kim, R. S., Avivar-Valderas, A., Estrada, Y., Bragado, P., Sosa, M. S., Aguirre-Ghiso, J. A., & Segall, J. E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035569 · Cited by 212
Kritikou, E. A., Sharkey, A., Abell, K., Came, P. J., Anderson, E., Clarkson, R. W. E., & Watson, C. J. (2003) · Development · doi:10.1242/dev.00578 · Cited by 201
Johnson, R. W., Nguyen, M. P., Padalecki, S. S., Grubbs, B. G., Merkel, A. R., Oyajobi, B. O., Matrisian, L. M., Mundy, G. R., & Sterling, J. A. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2993 · Cited by 197
Self-citationSTAT 3 the oncogene – still eluding therapy?
Wake, M. S., & Watson, C. J. (2015) · The FEBS Journal · doi:10.1111/febs.13285 · Cited by 188
Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance
Liu, S.-C., Tsang, N.-M., Chiang, W.-C., Chang, K.-P., Hsueh, C., Liang, Y., Juang, J.-L., Chow, K.-P. N., & Chang, Y.-S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63428 · Cited by 184
Adam, A. P., George, A., Schewe, D., Bragado, P., Iglesias, B. V., Ranganathan, A. C., Kourtidis, A., Conklin, D. S., & Aguirre-Ghiso, J. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3820 · Cited by 168
LIF promotes tumorigenesis and metastasis of breast cancer through the AKT-mTOR pathway
Li, X., Yang, Q., Yu, H., Wu, L., Zhao, Y., Zhang, C., Yue, X., Liu, Z., Wu, H., Haffty, B. G., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.1772 · Cited by 161
Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells
Touny, L. H. E., Vieira, A., Mendoza, A., Khanna, C., Hoenerhoff, M. J., & Green, J. E. (2013) · Journal of Clinical Investigation · doi:10.1172/jci70259 · Cited by 148
Osteoblasts display receptors for and responses to leukemia‐inhibitory factor
Allan, E. H., Hilton, D. J., Brown, M. A., Evely, R. S., Yumita, S., Metcalf, D., Gough, N. M., Ng, K. W., Nicola, N. A., & Martin, T. J. (1990) · Journal of Cellular Physiology · doi:10.1002/jcp.1041450116 · Cited by 134
Tausendschön, M., Dehne, N., & Brüne, B. (2011) · Cytokine · doi:10.1016/j.cyto.2010.11.002 · Cited by 132
Rathjen, P. D., Nichols, J., Toth, S., et al. (1990) · Genes & Development · doi:10.1101/gad.4.12b.2308 · Cited by 128
Microenvironments Dictating Tumor Cell Dormancy
Bragado, P., Sosa, M. S., Keely, P. J., Condeelis, J. S., & Aguirre‐Ghiso, J. A. (2012) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-642-28160-0_3 · Cited by 126
Jeong, C., Lee, H., Cha, J., Kim, J. H., Kim, K. R., Kim, J.-H., Yoon, D.-K., & Kim, K. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700534200 · Cited by 110
Johnson, R. W., Brennan, H. J., Vrahnas, C., Poulton, I. J., McGregor, N. E., Standal, T., Walker, E. C., Koh, T.-T., Nguyen, H., Walsh, N. C., et al. (2013) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2159 · Cited by 105
Self-citationBiswas, S., Nyman, J. S., Alvarez, J., Chakrabarti, A., Ayres, A., Sterling, J. A. R., Edwards, J., Rana, T., Johnson, R. W., Perrien, D. S., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027090 · Cited by 93
Self-citationIntegrin‐dependent response to laminin‐511 regulates breast tumor cell invasion and metastasis
Kusuma, N., Denoyer, D., Eble, J. A., Redvers, R. P., Parker, B. S., Pelzer, R., Anderson, R. L., & Pouliot, N. (2011) · International Journal of Cancer · doi:10.1002/ijc.26018 · Cited by 76
H3K9me3 facilitates hypoxia-induced p53-dependent apoptosis through repression of APAK
Olcina, M. M., Leszczyńska, K. B., Senra, J. M., Isa, N. F., Harada, H., & Hammond, E. M. (2015) · Oncogene · doi:10.1038/onc.2015.134 · Cited by 74
Self-citationOncostatin M Promotes Mammary Tumor Metastasis to Bone and Osteolytic Bone Degradation
Bolin, C., Tawara, K., Sutherland, C., Redshaw, J. D., Aranda, P., Moselhy, J., Anderson, R. L., & Jorcyk, C. L. (2012) · Genes & Cancer · doi:10.1177/1947601912458284 · Cited by 74
Nandy, S., Arumugam, A., Subramani, R., Pedroza, D. A., Hernandez, K. R., Saltzstein, E. C., & Lakshmanaswamy, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3953 · Cited by 70
HIF targets in bone remodeling and metastatic disease
Johnson, R. W., Schipani, E., & Giaccia, A. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.02.002 · Cited by 67
Self-citationLeukemia inhibitory factor: A paracrine mediator of bone metabolism
Sims, N. A., & Johnson, R. W. (2012) · Growth Factors · doi:10.3109/08977194.2012.656760 · Cited by 66
Self-citationTranscriptional changes induced by the tumor dormancy-associated microRNA-190
Almog, N., Briggs, C. E., Beheshti, A., Ma, L., Wilkie, K. P., Rietman, E. A., & Hlatky, L. (2013) · Transcription · doi:10.4161/trns.25558 · Cited by 58
Wang, N., Docherty, F., Brown, H. K., Reeves, K. J., Fowles, A. C. M., Lawson, M. A., Ottewell, P. D., Holen, I., Croucher, P. I., & Eaton, C. L. (2015) · The FASEB Journal · doi:10.1096/fj.14-266379 · Cited by 57
Iorns, E. J., Ward, T. M., Dean, S., Jegg, A. M., Thomas, D. G., Murugaesu, N., Sims, D., Mitsopoulos, C., Fenwick, K., Kozarewa, I., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2068-7 · Cited by 55
p53 induces angiogenesis-restricted dormancy in a mouse fibrosarcoma
Holmgren, L., Jackson, G., & Arbiser, J. L. (1998) · Oncogene · doi:10.1038/sj.onc.1201993 · Cited by 54
HIF-2α mediates hypoxia-induced LIF expression in human colorectal cancer cells
Wu, L., Yu, H., Zhao, Y., Zhang, C., Wang, J., Yue, X., Yang, Q., & Hu, W. (2015) · Oncotarget · doi:10.18632/oncotarget.3017 · Cited by 50
Targeting IL-6 and RANKL signaling inhibits prostate cancer growth in bone
Zheng, Y., Basel, D., Chow, S., Fong-Yee, C., Kim, S., Buttgereit, F., Dunstan, C. R., Zhou, H., & Seibel, M. J. (2014) · Clinical & Experimental Metastasis · doi:10.1007/s10585-014-9680-3 · Cited by 46
Razorenova, O. V., Castellini, L., Colavitti, R., Edgington‐Mitchell, L. E., Nicolau, M., Huang, X., Bedogni, B., Mills, E., Bogyo, M. S., & Giaccia, A. J. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00644-12 · Cited by 41
Self-citationRichard, V., Luchin, A. I., Brena, R. M., Plass, C., & Rosol, T. J. (2003) · Clinical Chemistry · doi:10.1373/49.8.1398 · Cited by 32
QSOX1 Inhibits Autophagic Flux in Breast Cancer Cells
Poillet-Perez, L., Pernodet, N., Boyer‐Guittaut, M., Adami, P., Borg, C., Jouvenot, M., Delage-Mourroux, R., & Despouy, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086641 · Cited by 23
Lee, H., & Kim, K. (2012) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2012.20.3.280 · Cited by 18
Cited by
Metastatic heterogeneity of breast cancer: Molecular mechanism and potential therapeutic targets
Liang, Y., Zhang, H., Song, X., & Yang, Q. (2020) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.012 · Cited by 992
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Understanding the Bone in Cancer Metastasis
Fornetti, J., Welm, A. L., & Stewart, S. A. (2018) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3618 · Cited by 526
Bone metastasis: mechanisms, therapies, and biomarkers
Clézardin, P., Coleman, R., Puppo, M., Ottewell, P., Bonnelye, E., Paycha, F., Confavreux, C. B., & Holen, I. (2021) · Physiological Reviews · doi:10.1152/physrev.00012.2019 · Cited by 416
Metastasis Organotropism: Redefining the Congenial Soil
Gao, Y., Bado, I., Wang, H., Zhang, W., Rosen, J. M., & Zhang, X. H.-F. (2019) · Developmental Cell · doi:10.1016/j.devcel.2019.04.012 · Cited by 380
Metadata
- Authors
- Johnson, R. W., Finger, E. C., Olcina, M. M., Vilalta, M., Aguilera, T., Miao, Y., Merkel, A. R., Johnson, J. R., Sterling, J. A., Wu, J. Y., & Giaccia, A. J.
- Venue
- Nature Cell Biology
- Published
- 2016-09-19
- Volume
- 18
- Issue
- 10
- Pages
- 1078-1089
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2522829580
- Cited by
- 262
- References
- 66
- FWCI
- 13.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.